BSE Live
Jan 21, 16:01Prev. Close
4058.35
Open Price
4035.35
Bid Price (Qty.)
4006.00 (3)
Offer Price (Qty.)
4057.50 (25)
NSE Live
Jan 21, 15:59Prev. Close
4051.90
Open Price
4051.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
4041.90 (21)
| Cash Flow of Sanofi India (in Rs. Cr.) | Dec 19 | Dec 18 | Dec 17 | Dec 16 | Dec 15 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 59.90 | 609.80 | 514.60 | 466.10 | 397.01 | |
| Net CashFlow From Operating Activities | 412.30 | 373.90 | 435.10 | 322.60 | 213.18 | |
| Net Cash Used In Investing Activities | 65.70 | -73.10 | -78.70 | -155.50 | 35.94 | |
| Net Cash Used From Financing Activities | -183.20 | -197.20 | -188.40 | -181.80 | -147.04 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | 294.80 | 103.60 | 168.00 | -14.70 | 102.08 | |
| Cash And Cash Equivalents Begin of Year | 825.10 | 721.50 | 553.50 | 567.80 | 465.66 | |
| Cash And Cash Equivalents End Of Year | 1,119.90 | 825.10 | 721.50 | 553.10 | 567.74 |
03.11.2025
Sanofi India Standalone September 2025 Net Sales at Rs 475.40 crore, down 9.27% Y-o-Y
01.08.2025
16.07.2025
Emcure Pharma announces deal with Sanofi India to distribute oral anti-diabetic products in India
15.05.2025
Sanofi India Standalone March 2025 Net Sales at Rs 535.90 crore, down 26.83% Y-o-Y
03.11.2025
Sanofi India Standalone September 2025 Net Sales at Rs 475.40 crore, down 9.27% Y-o-Y
15.05.2025
Sanofi India Standalone March 2025 Net Sales at Rs 535.90 crore, down 26.83% Y-o-Y
17.03.2025
Sanofi India Consolidated December 2024 Net Sales at Rs 514.90 crore, down 25.8% Y-o-Y
29.07.2024
Sanofi India Consolidated June 2024 Net Sales at Rs 463.50 crore, down 34.36% Y-o-Y